Literature DB >> 21886402

"Novel strategies to Improve Recombinant Factor VIII Production and its in vivo Recovery".

Raghuveer Prabhu1.   

Abstract

Year:  2010        PMID： 21886402      PMCID： PMC3002088          DOI： 10.1007/s12288-010-0036-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  6 in total

1.  Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein.

Authors:  A G Sarafanov; N M Ananyeva; M Shima; E L Saenko
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII.

Authors:  M Swaroop; M Moussalli; S W Pipe; R J Kaufman
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

3.  The Factor VIII acute phase response requires the participation of NFkappaB and C/EBP.

Authors:  M Begbie; C Notley; S Tinlin; L Sawyer; D Lillicrap
Journal:  Thromb Haemost       Date:  2000-08       Impact factor: 5.249

4.  Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.

Authors:  A J Gale; K-P Radtke; M A Cunningham; D Chamberlain; J-L Pellequer; J H Griffin
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

5.  Bioengineering of coagulation factor VIII for improved secretion.

Authors:  Hongzhi Z Miao; Nongnuch Sirachainan; Lisa Palmer; Phillip Kucab; Michael A Cunningham; Randal J Kaufman; Steven W Pipe
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

6.  An engineered interdomain disulfide bond stabilizes human blood coagulation factor VIIIa.

Authors:  A J Gale; J-L Pellequer
Journal:  J Thromb Haemost       Date:  2003-09       Impact factor: 5.824
  6 in total
  1 in total

Review 1.  The history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review.

Authors:  Hector E Castro; María Fernanda Briceño; Claudia P Casas; Juan David Rueda
Journal:  Indian J Hematol Blood Transfus       Date:  2012-11-04       Impact factor: 0.900
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.